Literature DB >> 22259622

Ischemic neuropathy associated with livedoid vasculitis.

Jee-Eun Kim1, Su-Yeon Park, Dong In Sinn, Sung-Min Kim, Yoon-Ho Hong, Kyung Seok Park, Jung-Joon Sung, Kwang-Woo Lee.   

Abstract

BACKGROUND: Livedoid vasculitis is a chronic dermatological problem with an unclear etiology. Clinical findings are petechiae with painful ulcers in both lower extremities, which heal to become hyperpigmented and porcelain-white satellite lesions. There are only a few reported cases of livedoid vasculitis presenting in combination with peripheral neuropathy. CASE REPORT: We report the first case of a Korean patient presenting with mononeuritis multiplex combined with livedoid vasculitis, which was confirmed by electrophysiological and pathological studies.
CONCLUSIONS: Our report supports the possible vaso-occlusive etiology of livedoid vasculitis in multifocal ischemic neuropathy.

Entities:  

Keywords:  livedoid vasculitis; livedoid vasculopathy; mononeuritis multiplex; multifocal ischemic neuropathy

Year:  2011        PMID: 22259622      PMCID: PMC3259500          DOI: 10.3988/jcn.2011.7.4.233

Source DB:  PubMed          Journal:  J Clin Neurol        ISSN: 1738-6586            Impact factor:   3.077


  24 in total

1.  Homocysteinemia and livedoid vasculitis.

Authors:  G E Gibson; H Li; M R Pittelkow
Journal:  J Am Acad Dermatol       Date:  1999-02       Impact factor: 11.527

2.  Livedo vasculitis with protein C system deficiency.

Authors:  M Baccard; M D Vignon-Pennamen; M Janier; M L Scrobohaci; L Dubertret
Journal:  Arch Dermatol       Date:  1992-10

Review 3.  Livedo (livedoid) vasculitis and the factor V Leiden mutation: additional evidence for abnormal coagulation.

Authors:  Kenneth T Calamia; Maria Balabanova; Charles Perniciaro; John S Walsh
Journal:  J Am Acad Dermatol       Date:  2002-01       Impact factor: 11.527

4.  Atrophie blanche. A disorder associated with defective release of tissue plasminogen activator.

Authors:  S V Pizzo; J C Murray; S L Gonias
Journal:  Arch Pathol Lab Med       Date:  1986-06       Impact factor: 5.534

5.  Livedo vasculitis. Segmental hyalinizing vasculitis of the dermis.

Authors:  J W Bard; R K Winkelmann
Journal:  Arch Dermatol       Date:  1967-11

6.  Use of intravenous immunoglobulin in livedo vasculitis.

Authors:  H Amital; Y Levy; Y Shoenfeld
Journal:  Clin Exp Rheumatol       Date:  2000 May-Jun       Impact factor: 4.473

7.  Minidose heparin therapy for vasculitis of atrophie blanche.

Authors:  R L Jetton; G S Lazarus
Journal:  J Am Acad Dermatol       Date:  1983-01       Impact factor: 11.527

Review 8.  Livedoid vasculopathy: thrombotic or inflammatory disease?

Authors:  S Khenifer; L Thomas; B Balme; S Dalle
Journal:  Clin Exp Dermatol       Date:  2010-10       Impact factor: 3.470

9.  Tissue plasminogen activator for treatment of livedoid vasculitis.

Authors:  K L Klein; M R Pittelkow
Journal:  Mayo Clin Proc       Date:  1992-10       Impact factor: 7.616

10.  Classification and therapy of atrophie blanche.

Authors:  L M Milstone; I M Braverman; P Lucky; P Fleckman
Journal:  Arch Dermatol       Date:  1983-12
View more
  3 in total

1.  Livedoid Vasculopathy and Mononeuritis Multiplex, with a Fulminant Hepatic Failure which was caused by Herpes Simplex Hepatitis: A Case Report.

Authors:  Sathish Pai B; Kanthilatha Pai
Journal:  J Clin Diagn Res       Date:  2013-03-15

2.  Livedoid vasculopathy associated with peripheral neuropathy: a report of two cases.

Authors:  Mariana Quirino Tubone; Gabriela Fortes Escobar; Juliano Peruzzo; Pedro Schestatsky; Gabriela Maldonado
Journal:  An Bras Dermatol       Date:  2013 Nov-Dec       Impact factor: 1.896

3.  Successful Treatment of Livedoid Vasculitis with Primary Antiphospholipid Syndrome by Using Aspirin and Low Dose Warfarin Combination Therapy.

Authors:  Byoung Joon So; Jae Beom Park; Min Gun Yoo; Il-Hwan Kim; Sang Wook Son
Journal:  Ann Dermatol       Date:  2015-10-02       Impact factor: 1.444

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.